{{Rsnum
|rsid=3769821
|Gene=CASP8
|Chromosome=2
|position=201258707
|Orientation=minus
|GMAF=0.416
|Gene_s=CASP8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 36.5 | 39.7 | 23.8
| HCB | 53.3 | 40.0 | 6.7
| JPT | 45.2 | 45.2 | 9.5
| YRI | 16.1 | 53.2 | 30.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 53.3 | 40.0 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21633787
|Title=Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients
}}{{PMID Auto
|PMID=19414860
|Title=Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
|OA=1
}}{{PMID Auto
|PMID=22843554
|Title=Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
|OA=1
}}